Apoptosis

Apoptosis

Cell membrane blebbing, chromatin condensation, genomic DNA fragmentation, and the exposure of particular phagocytosis signaling molecules on the cell surface are just a few of the distinctive morphological and biochemical features of the cell death process known as apoptosis. Apoptosis-initiated cell death is distinct from necrosis-induced cell death. Apoptotic death, in contrast, is silent and orderly. Necrotic cells are typically recognized as a danger signal by the immune system, which causes inflammation.

There are two main methods for inducing apoptotic cell death: The intrinsic pathway, also known as the Bcl-2-regulated or mitochondrial pathway, is strictly regulated by the BCL-2 family of proteins and is activated by a variety of developmental cues or cytotoxic insults, such as viral infection, DNA damage, and growth-factor deprivation.The tumor necrosis factor (TNF) receptor family members, such as Fas or TNF receptor-1 (TNFR1), which contain an intracellular death domain and can recruit and activate caspase-8 through the adaptor protein Fas-associated death domain (FADD; also known as MORT1) at the cell surface, are what initiate the extrinsic or death-receptor pathway. Without the involvement of the BCL-2 family, this recruitment results in the subsequent activation of downstream (effector) caspases like caspase-3, -6, or -7.

Numerous human diseases, including cancer, viral infections, autoimmune diseases, neurodegenerative disorders, and AIDS (acquired immunodeficiency syndrome), may be influenced by changes in cell survival, according to studies. Some of these diseases may not progress naturally unless specific therapies that change the apoptotic threshold are used.

Apoptosis related products

Structure Cat No. Product Name CAS No. Product Description
V53406 AKT-IN-3 2374740-21-1 AKT-IN-3 (compound E22) is a potent, oral, low-hERG-blocking Akt inhibitor (antagonist) with IC50s of 1.4 nM, 1.2 nM, and 1.7 nM for Akt1, Akt2, and Akt3, respectively.
V52433 AlbA-DCA 2413716-79-5 AlbA-DCA is a conjugate formed by linking Albiziabioside A (AlbA) to the dichloroacetic acid (DCA) subunit.
V52432 Albanol B 87084-99-9 Albanol B is an arylbenzofuran analogue extracted from mulberries.
V52429 Alisertib sodium (MLN 8237 sodium) 1028486-06-7 Aliertib (MLN 8237) sodium is an orally bioactive and selective Aurora A kinase inhibitor (IC50=1.2 nM).
V52428 Alisol F 24-acetate 443683-76-9 Alisol F 24-acetate is a triterpene compound extracted from the rhizome of Alisma orientalis.
V54834 ALK/EGFR-IN-1 2730430-08-5 ALK/EGFR-IN-1 (Compound 8l) is an ALK/EGFR dual (bifunctional) inhibitor that blocks the phosphorylation of EGFR and ALK.
V55022 Aloeresin G 287486-23-1 Aloeresin G is a chromone glycoside that can be extracted from Aloe.
V56450 Alogliptin-d3 (SYR-322-d3 (free base)) 1133421-35-8 Alogliptin-d3 is the deuterium labelled form of Alogliptin.
V52615 Amantadine-d15 (1-Adamantanamine-d15; 1-Aminoadamantane-d15) 33830-10-3 Amantadine-d15 is the deuterated form of Amantadine.
V52614 Amantadine-d6 (1-Adamantanamine-d6; 1-Aminoadamantane-d6) 1219805-53-4 Amantadine-d6 is the deuterated form of Amantadine.
V52555 Amiloride-15N3 hydrochloride (MK-870-15N3 hydrochloride) 1216796-18-7 Amiloride-15N3 ( HCl) is the deuterated form of Amiloride HCl.
V77934 Amoxetamide A Amoxetamide A is an anoikis inducer and displays anoikis-inducing activity on human colorectal cancer HT-29 cells.
V77265 AMXT-1501 tetrahydrochloride AMXT-1501 tetra HCl is an orally bioactive polyamine transport inhibitor.
V35054 Amyloid 17-42 (Aβ(17-42)) 155178-13-5 Amyloid 17-42 (Aβ(17-42)) is the major component of precerebellar amyloid in diffuse plaques in AD/Alzheimer's disease and Down syndrome, consisting of the alpha and gamma amyloid precursor protein (APP).
V30297 Angelicin (Isopsoralen) 523-50-2 Angelicin is a naturally occurring tricyclic aromatic hydrocarbon compound that is structurally related to psoralen and has anti-cancer, anti~inflammatory, anti-viral and other activities.
V34683 Angiotensin II human acetate (Angiotensin II acetate; Ang II acetate; DRVYIHPF acetate) 68521-88-0 Angiotensin II human (Angiotensin II) acetate is a vasoconstrictor and the major biologically active peptide of the renin/angiotensin system.
V34766 Angiotensin II human TFA (Angiotensin II TFA; Ang II TFA; DRVYIHPF TFA) 2761969-44-0 Angiotensin II human (Angiotensin II) TFA is a vasoconstrictor and the major biologically active peptide of the renin/angiotensin system.
V54825 Angophorol 133442-54-3 Angophorol is a flavonoid compound.
V56462 Antcin A 163597-24-8 Antcin A is an NLRP3 inhibitor that can suppress the assembly and activation of the NLRP3 inflammasome.
V52413 Anti-CSCs agent-1 2251753-58-7 Anti-CSCs agent-1 is an effective anti-CSCs agent.
Contact Us Back to top